Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation | BMC Cancer | Full Text

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation | BMC Cancer | Full Text

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell carcinoma of the bladder remains poorly studied. Ther...

Authors:Ronja Morsch, Michael Rose, Angela Maurer, Maria Angela Cassataro, Till Braunschweig, Ruth Knüchel, Thomas-Alexander Vögeli, Thorsten Ecke, Markus Eckstein, Veronika Weyerer, Irene Esposito, Maximilian Ackermann, Günter Niegisch and Nadine T. Gaisa

Citation:BMC Cancer 2020 20:230

Content type:Research article

Published on: 18 March 2020

• ViewFull Text
 
• ViewPDF